Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum

NCT04410562 is registered in ClinicalTrials.gov with Barcelona Institute for Global Health as lead sponsor.

NCT NCT04410562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04410562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum
Lead sponsor
Barcelona Institute for Global Health
Phase
Phase 3
Overall status
Completed
Start date
May 13, 2020
Completion date
October 31, 2021
Enrollment
129 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

covid, covid-19, pregnancy related